logo
Select company
Select metric
$ -92.64MEarning Before Interest & Taxes (EBIT)
VS
Market
10
Sector
22
Industry
31
History
76
$ 4.72Close
$ 1.13 - $ 5.34 52-Week Range
Ticker Information

Ticker

TSHA

Company Name

TAYSHA GENE THERAPIES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TAYSHA GENE THERAPIES INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TSHA - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -92.64M
3/31/2025$ -86.67M
12/31/2024$ -89.2M
9/30/2024$ -21.98M
6/30/2024$ -112.09M
3/31/2024$ -114.35M
12/31/2023$ -106.57M
9/30/2023$ -209.95M
6/30/2023$ -119.4M
3/31/2023$ -129.2M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TAYSHA GENE THERAPIES INC's latest trailing twelve months (TTM) EBIT stands at $ -59.98M.
  • Over the past 5 years, TAYSHA GENE THERAPIES INC's average EBIT has been $ -125.28M.
  • The median EBIT for TAYSHA GENE THERAPIES INC during this period was $ -116.88M
  • TAYSHA GENE THERAPIES INC reached its highest EBIT over the past 5 years at $ -21.98M.
  • The lowest EBIT recorded by TAYSHA GENE THERAPIES INC in the same timeframe $ -209.95M

TAYSHA GENE THERAPIES INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
RLAY : RELAY THERAPEUTICS INC $ -311.55MPRAX : PRAXIS PRECISION MEDICINES INC $ -251.01MLENZ : LENZ THERAPEUTICS INC $ -51.9MDNTH : DIANTHUS THERAPEUTICS INC $ -114.75MIMNM : IMMUNOME INC $ -212.39MTNXP : TONIX PHARMACEUTICALS HOLDING CORP $ -81.42MPRME : PRIME MEDICINE INC $ -199.28MNUVB : NUVATION BIO INC $ -202.21MPGEN : PRECIGEN INC $ -124.57MATAI : ATAI LIFE SCIENCES NV $ -116.63M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

TSHA - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -209.95M

Minimum

Sep 30, 2023

$ -21.98M

Maximum

Sep 30, 2024

$ -125.28M

Average

$ -116.88M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.62M with a standard deviation of $ 130.62M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.62M
median$ 897.02K
std$ 130.62M